Literature DB >> 16645710

Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma.

Hugues Duffau1, Luc Taillandier, Laurent Capelle.   

Abstract

While surgery is proned in low-grade glioma (LGG), the invasion of functional areas frequently prevents a complete resection. We report the first case of a patient operated on for a left frontal LGG, diagnosed because of seizures, with partial resection due to an invasion of the controlateral hemisphere. Chemotherapy enabled a regression of this controlateral extension. Postchemotherapy surgery performed with intraoperative functional mapping then allowed a complete resection, without sequelae. The patient has a normal socio-professional life, with no seizure. No other treatment was given. There was no recurrence, with a follow-up of 2 years since the second surgery (3.5 years since the first symptom). We propose a new therapeutic strategy in unresectable LGG, with preoperative chemotherapy, to make a radical surgery possible in a second step, while preserving the quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645710     DOI: 10.1007/s11060-006-9168-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns.

Authors:  Emmanuel Mandonnet; Laurent Capelle; Hugues Duffau
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

2.  Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.

Authors:  Elize M Biemond-ter Stege; Johan M Kros; Hein G de Bruin; R H Enting; Irene van Heuvel; Leendert H J Looijenga; Carin D D van der Rijt; Peter A E Sillevis Smitt; Martin J van den Bent
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

3.  Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.

Authors:  J A Nieuwenhuijzen; A Bex; W Meinhardt; J M Kerst; J H Schornagel; H VAN Tinteren; S Horenblas
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

Review 4.  Supratentorial grade II astrocytoma: biological features and clinical course.

Authors:  Peter H Wessels; Wim E J Weber; Guy Raven; Frans C S Ramaekers; Anton H N Hopman; Albert Twijnstra
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

5.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Authors:  B Fisher; J Bryant; N Wolmark; E Mamounas; A Brown; E R Fisher; D L Wickerham; M Begovic; A DeCillis; A Robidoux; R G Margolese; A B Cruz; J L Hoehn; A W Lees; N V Dimitrov; H D Bear
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  Preferential brain locations of low-grade gliomas.

Authors:  Hugues Duffau; Laurent Capelle
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

7.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Authors:  M S Berger; A V Deliganis; J Dobbins; G E Keles
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

8.  Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?

Authors:  Ashraf A Mosharafa; Richard S Foster; Bradley C Leibovich; Richard Bihrle; Cynthia Johnson; John P Donohue
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

9.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.

Authors:  A Pace; A Vidiri; E Galiè; M Carosi; S Telera; A M Cianciulli; P Canalini; D Giannarelli; B Jandolo; C M Carapella
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

10.  Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Authors:  K Hoang-Xuan; L Capelle; M Kujas; S Taillibert; H Duffau; J Lejeune; M Polivka; E Crinière; Y Marie; K Mokhtari; A F Carpentier; F Laigle; J M Simon; P Cornu; P Broët; M Sanson; J Y Delattre
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

View more
  9 in total

1.  Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps.

Authors:  Antonella Castellano; Marina Donativi; Roberta Rudà; Giorgio De Nunzio; Marco Riva; Antonella Iadanza; Luca Bertero; Matteo Rucco; Lorenzo Bello; Riccardo Soffietti; Andrea Falini
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

2.  Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma.

Authors:  Jasmin Jo; Brian Williams; Mark Smolkin; Max Wintermark; Mark E Shaffrey; M Beatriz Lopes; David Schiff
Journal:  J Neurooncol       Date:  2014-07-20       Impact factor: 4.130

3.  Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life.

Authors:  Marie Blonski; Luc Taillandier; Guillaume Herbet; Igor Lima Maldonado; Patrick Beauchesne; Michel Fabbro; Chantal Campello; Catherine Gozé; Valérie Rigau; Sylvie Moritz-Gasser; Christine Kerr; Roberta Rudà; Riccardo Soffietti; Luc Bauchet; Hugues Duffau
Journal:  J Neurooncol       Date:  2011-07-22       Impact factor: 4.130

Review 4.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 5.  Management of low-grade glioma.

Authors:  Nader Pouratian; David Schiff
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

6.  Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis.

Authors:  Michela Buglione; Sara Pedretti; Stefano Gipponi; Alice Todeschini; Ludovica Pegurri; Loredana Costa; Laura Donadoni; Salvatore Grisanti; Marco Fontanella; Roberto Liserre; Fabio Facchetti; Alessandro Padovani; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

7.  Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.

Authors:  Marie Blonski; Johan Pallud; Catherine Gozé; Emmanuel Mandonnet; Valérie Rigau; Luc Bauchet; Michel Fabbro; Patrick Beauchesne; Marie-Hélène Baron; Denys Fontaine; Philippe Peruzzi; Amélie Darlix; Hugues Duffau; Luc Taillandier
Journal:  J Neurooncol       Date:  2013-03-12       Impact factor: 4.130

8.  Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?

Authors:  Emmanuel Mandonnet; Michel Wager; Fabien Almairac; Marie-Helene Baron; Marie Blonski; Christian F Freyschlag; Fabio Barone; Denys Fontaine; Johan Pallud; Monika Hegi; Catarina Viegas; Maria Zetterling; Giannantonio Spena; John Goodden; Geert-Jan Rutten; Luc Taillandier; Nicolas Foroglu; Amélie Darlix; Miran Skrap; Juan Martino; Gord von Campe; Caterina Madadaki; Etienne Gayat; Philip de Witt Hamer; Santiago Gil Robles; Silvio Sarubbo; Thomas Santarius; Lorenzo Bello; Marie-Therese Forster; Hugues Duffau
Journal:  Neurooncol Pract       Date:  2017-01-17

9.  Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey.

Authors:  Osaama H Khan; Warren Mason; Paul N Kongkham; Mark Bernstein; Gelareh Zadeh
Journal:  J Neurooncol       Date:  2015-10-10       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.